Galapagos | Kundefordringer



Trade Debtors Endring Dato
AstraZeneca USD 14.83B 1.28B 2024-12
Biogen USD 1.87B 119.3M 2024-12
Genmab DKK 6.69B 381M 2024-12
Gilead Sciences USD 4.42B 167M 2024-12
GlaxoSmithKline GBP 7.32B 542M 2024-12
GRIFOLS EUR 871.58M 135.79M 2024-12
Hikma Pharmaceutical USD 965M 92M 2024-06
Incyte USD 853.15M 94.7M 2024-12
Merck EUR 4.59B 127M 2024-12
Neurocrine Biosciences USD 479.1M 2M 2024-12
Novartis USD 9B 854M 2024-12
Roche Holding CHF 13.46B 984M 2024-12
Sanofi 8.8B 2.24B 2024-06
UCB EUR 1.42B 132M 2024-06
Vertex Pharmaceuticals USD 1.61B 141.2M 2024-12



Galapagos Kundefordringer - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.